rs199842745
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_175614.5(NDUFA11):c.311G>T(p.Arg104Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000881 in 1,570,574 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_175614.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDUFA11 | NM_175614.5 | c.311G>T | p.Arg104Leu | missense_variant, splice_region_variant | 3/4 | ENST00000308961.5 | NP_783313.1 | |
NDUFA11 | NM_001193375.3 | c.311G>T | p.Arg104Leu | missense_variant, splice_region_variant | 3/4 | NP_001180304.1 | ||
NDUFA11 | NR_034166.3 | n.513G>T | splice_region_variant, non_coding_transcript_exon_variant | 4/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NDUFA11 | ENST00000308961.5 | c.311G>T | p.Arg104Leu | missense_variant, splice_region_variant | 3/4 | 1 | NM_175614.5 | ENSP00000311740 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000507 AC: 77AN: 152012Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000702 AC: 128AN: 182298Hom.: 0 AF XY: 0.000728 AC XY: 71AN XY: 97516
GnomAD4 exome AF: 0.000921 AC: 1307AN: 1418444Hom.: 1 Cov.: 35 AF XY: 0.000940 AC XY: 659AN XY: 701126
GnomAD4 genome AF: 0.000506 AC: 77AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.000444 AC XY: 33AN XY: 74366
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2022 | NDUFA11: PM2:Supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 08, 2019 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Mitochondrial complex I deficiency, nuclear type 1 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at